168 related articles for article (PubMed ID: 26420981)
1. Toxicity of polymeric nanoparticles in vivo and in vitro.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
J Nanopart Res; 2014 Jun; 16(6):. PubMed ID: 26420981
[TBL] [Abstract][Full Text] [Related]
2. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
3. How Nanoparticle Physicochemical Parameters Affect Drug Delivery to Cells in the Retina via Systemic Interactions.
You Q; Sokolov M; Grigartzik L; Hintz W; van Wachem BGM; Henrich-Noack P; Sabel BA
Mol Pharm; 2019 Dec; 16(12):5068-5075. PubMed ID: 31609624
[TBL] [Abstract][Full Text] [Related]
4. Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats.
Chung CY; Yang JT; Kuo YC
Biomaterials; 2013 Dec; 34(37):9717-27. PubMed ID: 24034503
[TBL] [Abstract][Full Text] [Related]
5. Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles.
You Q; Hopf T; Hintz W; Rannabauer S; Voigt N; van Wachem B; Henrich-Noack P; Sabel BA
J Drug Target; 2019 Mar; 27(3):338-346. PubMed ID: 30280953
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
[TBL] [Abstract][Full Text] [Related]
7. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity.
Olivier JC; Fenart L; Chauvet R; Pariat C; Cecchelli R; Couet W
Pharm Res; 1999 Dec; 16(12):1836-42. PubMed ID: 10644071
[TBL] [Abstract][Full Text] [Related]
8. Targeted Propolis-Loaded Poly (Butyl) Cyanoacrylate Nanoparticles: An Alternative Drug Delivery Tool for the Treatment of Cryptococcal Meningitis.
Thammasit P; Tharinjaroen CS; Tragoolpua Y; Rickerts V; Georgieva R; Bäumler H; Tragoolpua K
Front Pharmacol; 2021; 12():723727. PubMed ID: 34489710
[TBL] [Abstract][Full Text] [Related]
9. Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo.
Kolter M; Ott M; Hauer C; Reimold I; Fricker G
J Control Release; 2015 Jan; 197():165-79. PubMed ID: 25445700
[TBL] [Abstract][Full Text] [Related]
10. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells.
Kuo YC; Chung CY
Colloids Surf B Biointerfaces; 2012 Mar; 91():242-9. PubMed ID: 22137614
[TBL] [Abstract][Full Text] [Related]
11. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model.
Wang CX; Huang LS; Hou LB; Jiang L; Yan ZT; Wang YL; Chen ZL
Brain Res; 2009 Mar; 1261():91-9. PubMed ID: 19401168
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles.
Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C
Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136
[TBL] [Abstract][Full Text] [Related]
14. Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs.
Lin MH; Chung CY; Chen KT; Yeh JC; Lee TH; Lee MH; Lee IN; Huang WC; Yang JT
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621332
[TBL] [Abstract][Full Text] [Related]
15. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
[TBL] [Abstract][Full Text] [Related]
16. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
17. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
18. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
[TBL] [Abstract][Full Text] [Related]
19. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
20. Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting.
Tan R; Niu M; Zhao J; Liu Y; Feng N
J Drug Target; 2014 Jul; 22(6):509-17. PubMed ID: 24625287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
